Key Metrics
Company Snapshot
Rightway is a Healthcare company. Latest valuation $1.75B (As of Sep 25, 2026, PR Newswire). Total funding ~$281M (As of Sep 25, 2026).
Recent changes
- Sep 25, 2026Sep 25, 2026Raised $155M Series E at a $1.75B valuation PR Newswire
- Sep 25, 2026Sep 25, 2026First reported valuation: $1.75B PR Newswire
- Sep 25, 2026Sep 25, 2026First reported total funding: ~$281M PR Newswire
- Sep 25, 2026Sep 25, 2026New investor: Khosla Ventures PR Newswire
- Sep 25, 2026Sep 25, 2026New investor: Thrive Capital PR Newswire
Earlier changes (2)
- Sep 25, 2026Sep 25, 2026Rightway Raises $155M To Take On PBM Giants Pulse story
- Sep 9, 2026Sep 9, 2026Rightway Healthcare Quietly Raises $155M Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2026 | Series E | $155M | $1.75B | PR Newswire |
Investors
Latest Pulse
- Sep 28, 2026Health AI Raised $655M+ In Just Three DealsOpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.→
- Sep 25, 2026Rightway Raises $155M To Take On PBM GiantsRightway raised $155 million in Series E funding led by Francisco Partners, valuing the pharmacy-benefits and care-navigation startup at $1.75 billion as it takes aim at the CVS Caremark, Express Scripts and Optum Rx oligopoly.→
- Sep 9, 2026Rightway Healthcare Quietly Raises $155MRightway Healthcare closed a $155 million round disclosed only through an SEC filing, with no press release, named lead investor, or valuation -- unusually quiet for a company that has taken nearly $400 million since 2017.→
Coverage Timeline
newest firstAll Coverage
FUNDING$655M+ combined
Health AI Raised $655M+ In Just Three Deals
OpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.
BY THE NUMBERS
Rightway Raises $155M To Take On PBM Giants
FUNDING$155M Series E
Rightway Raises $155M To Take On PBM Giants
Rightway raised $155 million in Series E funding led by Francisco Partners, valuing the pharmacy-benefits and care-navigation startup at $1.75 billion as it takes aim at the CVS Caremark, Express Scripts and Optum Rx oligopoly.
DEEP DIVE
Related Companies
Shared investors
Rightway FAQ
What is Rightway's valuation?
Rightway's valuation is $1.75B (As of Sep 25, 2026, PR Newswire).
How much has Rightway raised?
Rightway has raised ~$281M in total funding (As of Sep 25, 2026, PR Newswire).
Who are Rightway's investors?
Rightway's investors include Khosla Ventures, Thrive Capital (As of Sep 25, 2026).
Sources & methodologyshow
Where these figures come from
- PR Newswireprimary source3 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.